U.S. Markets closed

Luminex Corporation (LMNX)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
19.23+0.28 (+1.48%)
At close: 4:00PM EDT

19.23 0.00 (0.00%)
After hours: 4:14PM EDT

People also watch

Luminex Corporation

12212 Technology Boulevard
Austin, TX 78727
United States

IndustryMedical Instruments & Supplies
Full Time Employees936

Key Executives

Mr. Nachum ShamirChief Exec. Officer, Pres and Director1.64MN/A63
Mr. Harriss T. CurrieChief Financial Officer, Sr. VP of Fin. and Treasurer667.03kN/A55
Mr. Richard W. Rew IISr. VP of Legal, Gen. Counsel and Corp. Sec.569.6kN/A49
Mr. Todd C. BennettSr. VP of Global Sales and Customer Operations537.28kN/A47
Mr. Randall J. MyersSr. VP of Global Manufacturing & Quality506.09kN/A55
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and life sciences industries worldwide. The company’s products include Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; Verigene system, an automated multiplex-capable system; and ARIES system, a sample to answer real-time PCR platform. It also offers MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; ARIES cassettes that are self-contained assay consumables; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; respiratory viral family of products to identify the causative agent for respiratory infections; and gastrointestinal pathogen panel assays to identify the pathogens causing infectious gastroenteritis. In addition, the company offers MultiCode assays and products comprising HSV 1&2 assays, analyte specific reagents, and other products to detect infectious agents in clinical samples; ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, and ARIES GBS assays; Verigene test cartridges; cystic fibrosis family of products comprising IVD kits for cystic fibrosis genotyping; pharmacogenetics family of products consisting of assays to determine the drug metabolism status; and specialty product family and instrumentation products, as well as operates as an original equipment manufacturer of custom reagents and instrumentation. It serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Corporate Governance

Luminex Corporation’s ISS Governance QualityScore as of August 1, 2017 is 4. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 5; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.